相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。p53 in ferroptosis regulation: the new weapon for the old guardian
Yanqing Liu et al.
CELL DEATH AND DIFFERENTIATION (2022)
Small-molecule MDM2 inhibitors in clinical trials for cancer therapy
Shuai Wang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)
Signal pathways and precision therapy of small-cell lung cancer
Min Yuan et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2022)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Evolution of DNA methylome from precancerous lesions to invasive lung adenocarcinomas
Xin Hu et al.
NATURE COMMUNICATIONS (2021)
MDM2 inhibitor APG-115 exerts potent antitumor activity and synergizes with standard-of-care agents in preclinical acute myeloid leukemia models
Douglas D. Fang et al.
CELL DEATH DISCOVERY (2021)
The lung-enriched p53 mutants V157F and R158L/P regulate a gain of function transcriptome in lung cancer
Julie A. Barta et al.
CARCINOGENESIS (2020)
Targeting codon 158 p53-mutant cancers via the induction of p53 acetylation
Li Ren Kong et al.
NATURE COMMUNICATIONS (2020)
Exosomes with low miR-34c-3p expression promote invasion and migration of non-small cell lung cancer by upregulating integrin α2β1
Wenjing Huang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Wild-Type p53 Promotes Cancer Metabolic Switch by Inducing PUMA-Dependent Suppression of Oxidative Phosphorylation
Jinchul Kim et al.
CANCER CELL (2019)
Deciphering the genomic, epigenomic, and transcriptomic landscapes of pre-invasive lung cancer lesions
Vitor H. Teixeira et al.
NATURE MEDICINE (2019)
Small molecule activators of the p53 response
Marcus J. G. W. Ladds et al.
JOURNAL OF MOLECULAR CELL BIOLOGY (2019)
Understanding Apoptosis and Apoptotic Pathways Targeted Cancer Therapeutics
Rehmat Jan et al.
ADVANCED PHARMACEUTICAL BULLETIN (2019)
Aggregation-Induced Fluorescence Probe for Monitoring Membrane Potential Changes in Mitochondria
Jun Li et al.
ACS APPLIED MATERIALS & INTERFACES (2018)
Serine 392 phosphorylation modulates p53 mitochondrial translocation and transcription-independent apoptosis
Cedric Castrogiovanni et al.
CELL DEATH AND DIFFERENTIATION (2018)
Phthalazino[1,2-b]quinazolinones as p53 Activators: Cell Cycle Arrest, Apoptotic Response and Bak-Bcl-xl Complex Reorganization in Bladder Cancer Cells
Guo-Hai Zhang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
THE GREATEST HITS OF THE HUMAN GENOME
Elie Dolgin
NATURE (2017)
Reviving the guardian of the genome: Small molecule activators of p53
Daniel Nguyen et al.
PHARMACOLOGY & THERAPEUTICS (2017)
Kevetrin induces p53-dependent and independent cell cycle arrest and apoptosis in ovarian cancer cell lines representing heterogeneous histologies
Ashok Kumar et al.
CANCER RESEARCH (2017)
Results of the Phase I Trial of RG7112, a Small-Molecule MDM2 Antagonist in Leukemia
Michael Andreeff et al.
CLINICAL CANCER RESEARCH (2016)
A Novel Naphthalimide Compound Restores p53 Function in Non-small Cell Lung Cancer by Reorganizing the Bak•Bcl-xl Complex and Triggering Transcriptional Regulation
Guohai Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
p53 in the DNA-Damage-Repair Process
Ashley B. Williams et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2016)
Growth factors mediated cell signalling in prostate cancer progression: Implications in discovery of anti-prostate cancer agents
Gaurav Joshi et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2015)
A phase 1, dose-escalation, safety, pharmacokinetic, pharmacodynamic study of thioureidobutyronitrile, a novel p53 targeted therapy, in patients with advanced solid tumors.
Geoffrey Shapiro et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Unravelling mechanisms of p53-mediated tumour suppression
Kathryn T. Bieging et al.
NATURE REVIEWS CANCER (2014)
Discovery of RG7388, a Potent and Selective p53-MDM2 Inhibitor in Clinical Development
Qingjie Ding et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Kevetrin targets both MDM2-p53 and Rb-E2F pathways in tumor suppression
Ashok Kumar et al.
CANCER RESEARCH (2012)
Effect of the MDM2 antagonist RG7112 on the P53 pathway in patients with MDM2-amplified, well-differentiated or dedifferentiated liposarcoma: an exploratory proof-of-mechanism study
Isabelle Ray-Coquard et al.
LANCET ONCOLOGY (2012)
Kevetrin™, a novel small molecule, activates p53, enhances expression of p21, induces cell cycle arrest and apoptosis in a human cancer cell line
Ashok Kumar et al.
CANCER RESEARCH (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Reduced p21WAF1/CIP1 via Alteration of p53-DDX3 Pathway Is Associated with Poor Relapse-Free Survival in Early-Stage Human Papillomavirus-Associated Lung Cancer
De-Wei Wu et al.
CLINICAL CANCER RESEARCH (2011)
p53 and autophagy in cancer: Guardian of the genome meets guardian of the proteome
Kevin M. Ryan
EUROPEAN JOURNAL OF CANCER (2011)
p53 Prevents Entry into Mitosis with Uncapped Telomeres
Maria Thanasoula et al.
CURRENT BIOLOGY (2010)
Selective activation of p53-mediated tumour suppression in high-grade tumours
Melissa R. Junttila et al.
NATURE (2010)
Stage-specific sensitivity to p53 restoration during lung cancer progression
David M. Feldser et al.
NATURE (2010)
Blinded by the Light: The Growing Complexity of p53
Karen H. Vousden et al.
CELL (2009)
Cell cycle, CDKs and cancer: a changing paradigm
Marcos Malumbres et al.
NATURE REVIEWS CANCER (2009)
Restoration of p53 to limit tumor growth
Wenge Wang et al.
CURRENT OPINION IN ONCOLOGY (2008)
The absence of Ser389 phosphorylation in p53 affects the basal gene expression level of many p53-dependent genes and alters the biphasic response to UV exposure in mouse embryonic fibroblasts
Wendy Bruins et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Transcriptional control of human p53-regulated genes
Todd Riley et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
Human papillomavirus 16/18 E6 oncoprotein is expressed in lung cancer and related with p53 inactivation
Ya-Wen Cheng et al.
CANCER RESEARCH (2007)
2,2,2-Trichloro-N-({2-[2-(dimethylamino)ethyl]-1,3-dioxo-2,3-dihydro-1H-benzo[de]isoquinolin5-yl} carbamoyl) acetamide (UNBS3157), a novel nonhematotoxic naphthalimide derivative with potent antitumor activity
Eric Van Quaquebeke et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Mitochondrial membrane permeabilization in cell death
Guido Kroemer et al.
PHYSIOLOGICAL REVIEWS (2007)
A global map of p53 transcription-factor binding sites in the human genome
CL Wei et al.
CELL (2006)
Lack of p53 Ser389 phosphorylation predisposes mice to develop 2-acetylaminofluorene-induced bladder tumors but not ionizing radiation-induced lymphomas
EM Hoogervorst et al.
CANCER RESEARCH (2005)
Elevated c-Jun expression in acute myeloid leukemias inhibits C/EBPα DNA binding via leucine zipper domain interaction
J Rangatia et al.
ONCOGENE (2003)
To cycle or not to cycle: A critical decision in cancer
M Malumbres et al.
NATURE REVIEWS CANCER (2001)
Interplay of p53 and DNA-repair protein XRCC4 in tumorigenesis, genomic stability and development
YJ Gao et al.
NATURE (2000)
分享论文
